ahlam1399
06-01-2015, 09:30 PM
UPDATE 1-Large U.S. cancer trial to match genetic glitches to targeted *****
CHICAGO, June 1 (Reuters) - The National Cancer Institute in July will start enrolling patients in a clinical trial seeking to match the underlying genetic defect driving a person's tumor with one or more of 20 approved or experimental ***** targeting that gene.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46d5e4b0/sc/14/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SZFzwWXuXGw:GOLh3V47O78:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SZFzwWXuXGw:GOLh3V47O78:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/SZFzwWXuXGw
CHICAGO, June 1 (Reuters) - The National Cancer Institute in July will start enrolling patients in a clinical trial seeking to match the underlying genetic defect driving a person's tumor with one or more of 20 approved or experimental ***** targeting that gene.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46d5e4b0/sc/14/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SZFzwWXuXGw:GOLh3V47O78:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SZFzwWXuXGw:GOLh3V47O78:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=SZFzwWXuXGw:GOLh3V47O78:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/SZFzwWXuXGw